findmyKOL
Clinical trialNCT03828682UnknownPhase 4Interventional

Veloxis de Novo Kidney Transplant ECSWD

SponsorSimon Tremblay, PharmD, PhDEnrollment60ImmunosuppressionKidney Transplantation
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is designed to evaluate the safety and efficacy of LCPT in combination with rATG, mycophenolate and early corticosteroid withdrawal (CSWD) in de novo kidney transplant recipients.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the Christ Hospital

    Cincinnati, Ohio, United States

    Adele Rike-Shields, PharmDErvin S Woodle, MD
    Recruiting
  • University of Cincinnati

    Cincinnati, Ohio, United States

    Amit Govil, MDErvin S Woodle, MDRita R Alloway, PharmD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Methylprednisolone →Mycophenolate mofetil →Mycophenolic acidPrednisone →Rabbit Anti-Human T-Lymphocyte Globulin Injectable Solution [Thymoglobulin]Tacrolimus →Tacrolimus Extended Release Oral Tablet [Envarsus]
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Jun 2019
Primary completion
31 Jul 2021
Completion
30 Jun 2022
Last update posted
13 May 2020
Registered enrollment
60
Registry id
NCT03828682

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.